Bei Wang
Bei Wang, MD, PhD, is Director of Oncology and Immuno-Oncology at Regeneron, where she focuses on translating fundamental insights in tumor immunology into novel therapeutic approaches. Her research has spanned dendritic cell biology, T-cell activation and costimulation, tumor immune regulation, and antibody-based cancer immunotherapy. She trained in the laboratory of Ralph Steinman at The Rockefeller University, where her work focused on dendritic cell-targeted cancer immunotherapy. At Regeneron, she has contributed to the discovery and development of new immunotherapeutic approaches, including tumor-targeted CD28 costimulatory bispecific antibodies and combination immunotherapies.
Abstracts this author is presenting:
